Interleaving Stimulation Improves Dyskinesia in Parkinson's Disease - Trial NCT06239454
Access comprehensive clinical trial information for NCT06239454 through Pure Global AI's free database. This phase not specified trial is sponsored by Huashan Hospital and is currently Recruiting. The study focuses on Parkinson's Disease. Target enrollment is 50 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Huashan Hospital
Timeline & Enrollment
N/A
Mar 01, 2022
Feb 28, 2025
Primary Outcome
dyskinesia scores (United Parkinson's Disease Rating Scale Part IV, item 32 + item 33),Parkinson's disease quality of life-39 (PDQ-39) scores
Summary
This study is designed as a prospective, randomized, double-blind, controlled study to assess
 putative differences in the effect of interleaving stimulation and empirical stimulation with
 regards to post-operation dyskinesia control. The primary objective is to assess putative
 differences in the effect of interleaving stimulation and empirical stimulation with regards
 to dyskinesia control.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06239454
Device Trial